-
Athero- and Aneurysm-Express Biobank Studies
The Athero-Express Biobank Study (AE) and the Abdominal Aortic Aneurysm-Express Biobank Study (AAA) are two ongoing, prospective biobank studies initiated in 2002 and 2003,... -
'Utrecht cohort for Multiple BReast cancer intErvention studies and...
The prospective, multicenter ‘Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluAtion’ (UMBRELLA) cohort, established in 2013, serves as an... -
MARS - Molecular Diagnosis and Risk Stratification of Sepsis
MARS is a multicenter prospective cohort of ICU patients aimed at developing new molecular technologies for early diagnosis and risk stratification of sepsis. MARS contains... -
European Prospective Investigation Into Cancer and Nutrition in the...
EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed... -
Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the...
Inflammatory Bowel Diseases (IBD), i.e. Crohn’s Disease (CD) and Ulcerative Colitis (UC), are thought to arise in genetically susceptible individuals in the context of... -
Virus Interactions in the Respiratory Tract; a Cohort Study With Children (VIOOL)
The VIOOL study is a prospective observational cohort conducted across three winter seasons (2021–2024; October–April/May) in the Netherlands. Children under 4 years of age were... -
BioDay Registry
The BioDay registry is a disease or condition registry for atopic dermatitis (AD)/prurigo nodularis (PN). All patients treated with advanced systemic therapy (biologics and JAK... -
PROTOCOL ALL 11: Treatment study protocol of the Dutch Childhood Oncology...
- To improve the overall outcome as compared to the previous protocols of the DCOG, especially ALL-9 and ALL-10. This is aimed for by decreasing therapy for part of the...
-
Protocol ALL 10, protocol voor diagnostiek en behandeling van kinderen en...
The aim of Protocol ALL-10 is to improve the overall treatment results in terms of EFS and to decrease treatment intensity in patients with a pEFS of >95%. Therapy will be...